Bone Health: AGA2118 for Postmenopausal Women

We are studying whether AGA2118 can improve bone density in postmenopausal women with low bone mass. The trial compares its effects to a placebo over 12 months.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Aga2118

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
University Multiprofessional Hospital For Active Treatment Plovdiv AD
Department of Rheumatology
Plovdiv, Bulgaria
Diagnostic Consultative Centre Ascendent EOOD
Tutrakan, Bulgaria
Aalborg University Hospital
Clinical Institute and Department of Endocrinology, Aalborg Hospital
Aalborg, Denmark

Sponsor: Angitia Inc. Ltd.
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.